Abstract
The long-term efficacy of percutaneous coronary intervention for mildly obstructive
coronary narrowings is limited by the occurrence of restenosis, limiting the applicability
of this therapy for these lesions. The present study reports on a consecutive series
of 20 patients treated with sirolimus-eluting stent implantation for 23 angiographically
mild de novo lesions (defined as a diameter stenosis <50% by quantitative coronary
angiography). At a mean follow-up of 399 ± 120 days, the survival-free of major adverse
events was 95%, with no patient requiring target lesion revascularization.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Acute coronary syndromes.Lancet. 1999; 353: SII5-SII9
- Coronary plaque disruption.Circulation. 1995; 92: 657-671
- Angiographic progression of coronary artery disease and the development of myocardial infarction.J Am Coll Cardiol. 1988; 12: 56-62
- Healed plaque ruptures and sudden coronary death.Circulation. 2001; 103: 934-940
- Lessons from sudden coronary death.Arterioscler Thromb Vasc Biol. 2000; 20: 1262-1275
- Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction.Heart. 1999; 82: 269-272
- Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.Eur Heart J. 2003; 24: 541-551
- Morphological predictors of restenosis after coronary stenting in humans.Circulation. 2002; 105: 2974-2980
- Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes.J Am Coll Cardiol. 2003; 41: 2093-2099
Lemos PA, Serruys PW, Van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world.” The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004;109:190–195
- A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med. 2002; 346: 1773-1780
- Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings.Circulation. 1999; 100: 256-261
- Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements.Am J Cardiol. 2002; 90: 1160-1164
- Safety of deferring angioplasty in patients with normal coronary flow velocity reserve.J Am Coll Cardiol. 1999; 33: 82-87
- Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement.J Am Coll Cardiol. 1998; 31: 841-847
- Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis.Circulation. 2001; 103: 2928-2934
- Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis.Am J Cardiol. 2002; 89: 377-380
- Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease.J Am Coll Cardiol. 2002; 39: 852-858
Article info
Publication history
Accepted:
March 19,
2004
Received in revised form:
March 19,
2004
Received:
December 22,
2003
Identification
Copyright
© 2004 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
